226 related articles for article (PubMed ID: 12409060)
1. Tamoxifen versus raloxifene in the prevention of breast cancer.
Wickerham DL
Eur J Cancer; 2002 Nov; 38 Suppl 6():S20-1. PubMed ID: 12409060
[No Abstract] [Full Text] [Related]
2. Breast cancer hopes.
Zurlinden J
Nurs Spectr (Wash D C); 1998 Jun; 8(11):17-8. PubMed ID: 10542741
[No Abstract] [Full Text] [Related]
3. STAR trial reports.
Eur J Cancer; 2006 Aug; 42(12):1694. PubMed ID: 16998956
[No Abstract] [Full Text] [Related]
4. STAR: first-year recruitment efforts set brisk pace for future.
CA Cancer J Clin; 2000; 50(5):271-2. PubMed ID: 11075236
[No Abstract] [Full Text] [Related]
5. Tamoxifen prevention of breast cancer: an instance of the fingerpost.
Lippman SM; Brown PH
J Natl Cancer Inst; 1999 Nov; 91(21):1809-19. PubMed ID: 10547388
[No Abstract] [Full Text] [Related]
6. Breast cancer prevention trials.
Rhodes DJ; Hartmann LC; Perez EA
Curr Oncol Rep; 2000 Nov; 2(6):558-65. PubMed ID: 11122893
[TBL] [Abstract][Full Text] [Related]
7. Upstaging tamoxifen? New classes of drugs emerging for breast cancer.
Twombly R
J Natl Cancer Inst; 2002 Apr; 94(7):474-5. PubMed ID: 11929942
[No Abstract] [Full Text] [Related]
8. [Prevention of breast cancer 2007. New evidence?].
Marzo Castillejo M
Aten Primaria; 2007 Mar; 39(3):115-7. PubMed ID: 17386201
[No Abstract] [Full Text] [Related]
9. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
Chlebowski RT; Col N; Winer EP; Collyar DE; Cummings SR; Vogel VG; Burstein HJ; Eisen A; Lipkus I; Pfister DG;
J Clin Oncol; 2002 Aug; 20(15):3328-43. PubMed ID: 12149307
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer prevention.
Rodabaugh KJ; Bloss JD
Clin Obstet Gynecol; 2001 Sep; 44(3):478-84. PubMed ID: 11685873
[No Abstract] [Full Text] [Related]
11. Breast cancer highlights.
Kuter I
Oncologist; 1999; 4(4):299-308. PubMed ID: 10476541
[No Abstract] [Full Text] [Related]
12. Chemoprevention of breast cancer: recommendations and rationale.
Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459
[No Abstract] [Full Text] [Related]
13. Breast cancer prevention study aims to overcome drug bias.
Vastag B
JAMA; 2001 Jan 24-31; 285(4):399-400. PubMed ID: 11242406
[No Abstract] [Full Text] [Related]
14. Tamoxifen and contralateral breast cancer: the other side.
Swain SM
J Natl Cancer Inst; 2001 Jul; 93(13):963-5. PubMed ID: 11438553
[No Abstract] [Full Text] [Related]
15. Current controversies in breast cancer management.
Morrow M; Jordan VC; Takei H; Gradishar WJ; Pierce LJ
Curr Probl Surg; 1999 Mar; 36(3):163-216. PubMed ID: 10089889
[No Abstract] [Full Text] [Related]
16. Chemoprevention of breast cancer.
Thomsen A; Kolesar JM
Am J Health Syst Pharm; 2008 Dec; 65(23):2221-8. PubMed ID: 19020189
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG
J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of antiestrogens for prevention of breast cancer.
Reddy P; Chow MS
Am J Health Syst Pharm; 2000 Jul; 57(14):1315-22; quiz 1323-5. PubMed ID: 10918921
[TBL] [Abstract][Full Text] [Related]
19. Anti-estrogens come of age: a pioneer looks back.
Nelson NJ
J Natl Cancer Inst; 1998 May; 90(9):646-7. PubMed ID: 9586657
[No Abstract] [Full Text] [Related]
20. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
Powles TJ
J Natl Cancer Inst; 1999 Apr; 91(8):730. PubMed ID: 10218518
[No Abstract] [Full Text] [Related]
[Next] [New Search]